Xenon Pharmaceuticals Inc (XENE)
43.75
+0.75
(+1.74%)
USD |
NASDAQ |
May 03, 16:00
43.75
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Market Cap: 3.302B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.302B |
| May 02, 2024 | 3.245B |
| May 01, 2024 | 3.206B |
| April 30, 2024 | 3.068B |
| April 29, 2024 | 3.225B |
| April 26, 2024 | 3.056B |
| April 25, 2024 | 3.026B |
| April 24, 2024 | 2.981B |
| April 23, 2024 | 3.101B |
| April 22, 2024 | 3.019B |
| April 19, 2024 | 3.009B |
| April 18, 2024 | 3.042B |
| April 17, 2024 | 3.142B |
| April 16, 2024 | 3.131B |
| April 15, 2024 | 3.117B |
| April 12, 2024 | 3.117B |
| April 11, 2024 | 3.243B |
| April 10, 2024 | 3.202B |
| April 09, 2024 | 3.247B |
| April 08, 2024 | 3.216B |
| April 05, 2024 | 3.188B |
| April 04, 2024 | 3.184B |
| April 03, 2024 | 3.115B |
| April 02, 2024 | 3.128B |
| April 01, 2024 | 3.179B |
| Date | Value |
|---|---|
| March 28, 2024 | 3.247B |
| March 27, 2024 | 3.244B |
| March 26, 2024 | 3.218B |
| March 25, 2024 | 3.221B |
| March 22, 2024 | 3.319B |
| March 21, 2024 | 3.278B |
| March 20, 2024 | 3.303B |
| March 19, 2024 | 3.345B |
| March 18, 2024 | 3.235B |
| March 15, 2024 | 3.316B |
| March 14, 2024 | 3.294B |
| March 13, 2024 | 3.400B |
| March 12, 2024 | 3.338B |
| March 11, 2024 | 3.347B |
| March 08, 2024 | 3.488B |
| March 07, 2024 | 3.482B |
| March 06, 2024 | 3.467B |
| March 05, 2024 | 3.470B |
| March 04, 2024 | 3.466B |
| March 01, 2024 | 3.533B |
| February 29, 2024 | 3.560B |
| February 28, 2024 | 3.609B |
| February 27, 2024 | 3.744B |
| February 26, 2024 | 3.706B |
| February 23, 2024 | 3.728B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
209.79M
Minimum
Oct 09 2019
3.772B
Maximum
Feb 09 2024
1.397B
Average
1.371B
Median
Dec 15 2021
Market Cap Benchmarks
| Acasti Pharma Inc | 27.82M |
| Aurinia Pharmaceuticals Inc | 729.40M |
| Edesa Biotech Inc | 14.69M |
| Lexaria Bioscience Corp | 40.33M |
| ESSA Pharma Inc | 304.36M |
Market Cap Related Metrics
| PS Ratio | 222.18 |
| PEG Ratio | -1.143 |
| Price to Book Value | 3.558 |
| Price | 43.75 |
| Earnings Yield | -6.22% |
| PEGY Ratio | -1.143 |